Morgan Stanley’s Telomir Pharmaceuticals TELO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.8K | Sell |
25,407
-3,616
| -12% | -$4.52K | ﹤0.01% | 6505 |
|
|
2025
Q1 | $93.7K | Sell |
29,023
-11,198
| -28% | -$36.2K | ﹤0.01% | 6041 |
|
|
2024
Q4 | $166K | Buy |
40,221
+28,767
| +251% | +$119K | ﹤0.01% | 5860 |
|
|
2024
Q3 | $73.5K | Buy |
11,454
+6,255
| +120% | +$40.2K | ﹤0.01% | 6106 |
|
|
2024
Q2 | $25K | Buy |
+5,199
| New | +$25K | ﹤0.01% | 6386 |
|